复发或难治性大B细胞淋巴瘤患者挽救化疗后残留病灶接受自体干细胞移植前正电子发射断层扫描衍生指标的预后价值
该单中心回顾性分析纳入92例挽救化疗后达部分缓解或疾病稳定并接受自体干细胞移植的复发或难治性大B细胞淋巴瘤患者,计算移植前PET的D-5PS评分、SUVmax、TMTV和TLG。5年无进展生存率和总生存率分别为40%和54%;D-5PS评分5分、高SUVmax、高TMTV和高TLG与更差的无进展生存相关,D-5PS评分5分和高SUVmax与更差的总生存相关。
要点
- 移植前PET的D-5PS评分5分与更差的无进展生存(HR 2.09)和总生存(HR 1.98)相关。
- 高SUVmax与更差的无进展生存(HR 2.48)和总生存(HR 2.55)相关。
- 高TMTV(HR 1.83)和高TLG(HR 2.27)与更差的无进展生存相关。
核心结论
- PET衍生参数可能有助于对挽救化疗后残留病灶的复发或难治性大B细胞淋巴瘤患者行自体干细胞移植后的结局进行预后判断。
研究设计与样本
- 单中心回顾性分析,纳入92例挽救化疗后达部分缓解或疾病稳定并接受自体干细胞移植的复发或难治性大B细胞淋巴瘤患者。
- 从挽救化疗后/自体干细胞移植前的PET扫描计算D-5PS评分、SUVmax、TMTV和TLG。
主要发现
- 5年无进展生存率和总生存率分别为40%和54%。
- D-5PS评分5分(p=0.0082,HR 2.09)、高SUVmax(p=0.0015,HR 2.48)、高TMTV(p=0.035,HR 1.83)和高TLG(p=0.0036,HR 2.27)与更差的无进展生存相关。
- D-5PS评分5分(p=0.030,HR 1.98)和高SUVmax(p=0.0025,HR 2.55)与更差的总生存相关。
临床怎么用
- 作者认为,PET衍生参数可能有助于对挽救化疗后残留病灶的复发或难治性大B细胞淋巴瘤患者行自体干细胞移植后的结局进行预后判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Salvage chemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) is a potentially curative treatment for patients with relapsed or refractory large B-cell lymphoma (rrLBCL) with chemosensitive disease. A18 F-fluorodeoxyglucose positron emission tomography (PET) scan after salvage chemotherapy is used to assess response and eligibility for ASCT, but metrics for chemosensitivity in patients with residual disease are not well defined. We performed a single-centre retrospective analysis of 92 patients with a partial response or stable disease after salvage chemotherapy for rrLBCL who received ASCT to investigate PET-derived parameters and their prognostic utility. The Deauville 5-point Scale (D-5PS) score, maximum standardised uptake value (SUVmax ), total metabolic tumour volume (TMTV), and total lesion glycolysis (TLG) were calculated from the post-salvage/pre-ASCT PET scan. The 5-year progression-free survival (PFS) and overall survival (OS) rates were 40% and 54% respectively. A D-5PS score of 5 (p = 0.0082, hazard ratio [HR] 2.09), high SUVmax (p = 0.0015, HR 2.48), TMTV (p = 0.035, HR 1.83) and TLG (p = 0.0036, HR 2.27) were associated with inferior PFS. A D-5PS score of 5 (p = 0.030, HR 1.98) and high SUVmax (p = 0.0025, HR 2.55) were associated with inferior OS. PET-derived parameters may help prognosticate outcomes after ASCT in patients with rrLBCL with residual disease after salvage chemotherapy.
引用
- Cherng HJ, Xu G, Feng L, et al. Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant. Br J Haematol. 2022. PMID: 36068929. doi:10.1111/bjh.18441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。